A personal path to pain research
After over 20 years of academic research in somatosensory function and the development of peripheral neural innervation, the research of Dr. Frank L. Rice took on new urgency when a carpenter friend of his sustained a life-altering shoulder injury as a result of a seemingly minor workplace incident. What appeared as a commonplace injury turned tragic as this healthy father of four began suffering with intense pain and arm dysfunction that severely limited his quality of life, including the ability to work or even hug his family. The excruciating pain was too intense.
At that point, Dr. Rice shifted his world renown expertise in normal and developmental neurobiology to investigate pain mechanisms and peripheral neuropathic afflictions, doing all that he could to help his friend. By applying what he has learned in the academic setting and worldwide networking with other top pain scientists, Dr. Rice has now been part of published landmark discoveries in several debilitating disorders, including Fibromyalgia as well as Complex Regional Pain Syndrome (formerly known as Reflex Sympathetic Dystrophy, RSD), which remains the diagnosis of his friend.
Dr. Rice’s interest and important contributions to pain science were crucial to the founding of INTiDYN and continue with the research work produced. Dr. Rice is a global thought leader in pain mechanisms and an outspoken advocate for increased awareness and funding for pain-related research.
Dr. Phillip J. Albrecht is a scientific innovator and thought leader who brought a wealth of academic and industry research experience to the founding of INTiDYN. Dr. Albrecht has a well-documented history of research in neuroscience, including pain mechanisms, glial biology, CNS injury, and peripheral pathology associated with chronic pain. His published works are considered essential to the recently evolving novel theories of primary nociception and pain perception.
INTiDYN continues to provide companies of all sizes research expertise and experience to make best use of the resources available and deliver valuable studies and actionable data to better understand pain mechanisms and create novel next generation therapies.
INTiDYN is committed to the research required to discover and develop novel treatments for pain, particularly therapies that provide a safe, effective alternatives to opiates, as the use of opiates for pain management is being curtailed for several widely publicized reasons.